TCT 2018 | SYNTAXES: 10 Year Follow Up is ‘Trendy’

The SYNTAX trial had a 5-year follow-up, but the SYNTAXES (“ES” for extended survival) was specifically designed to find out comparative mortality of both treatments (PCI or surgery) at 10 years in patients with three vessel and/or left main lesions.

TCT 2018 | SYNTAXES: el seguimiento a 10 años se puso de modaThis study retrospectively compared survival data at long term of 897 patients randomized to surgery and 907 patients randomized to PCI from the original SYNTAX.

 

Mortality at 5 years had been 13.9% for PCI vs 11.9% for surgery (CABG) (p=0.1); the difference in favor of surgery was in the combined events rate (37.3% vs 26.9%; p<0.001).

 

Data at 10 years on mortality rendered parallel curves, following the prior 5-year trend (29.4% vs 25.6%; p<0.1). That is when looking at the general population, but when assessing only patients admitted for three vessel disease, we observed a trend in favor of surgery (29,2% vs 21,9%, p=0,07). This trend could not be documented in other subgroups of patients such as diabetics or patients with left main disease.


Read also: TCT 2018 | PREPARE-CALC: Rotational Atherectomy vs. Cutting Balloon in Calcified Lesions.


These outcomes can be considered exploratory since only 72% of the general populations could be followed up to 10 years.

 

Original title: 10- Year Survival after Bypass Surgery versus Drug-Eluting Stents: Preliminary Results of the Randomized SYNTAX Extended Survival study – “SYNTAXES”.

Presenter: Daniel J.F.M. Thuijs.

 

SYNTAXES-presentación


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...